Skip to main content
. 2023 Apr 26;8(5):101256. doi: 10.1016/j.adro.2023.101256

Table 3.

Comparison of OAR dose between the scheduled and adapted plans

OAR Number Scheduled plan (cGy) Adapted plan (cGy) Difference over a treatment course* (Gy) Mean % difference Minimum relative difference (%) Maximum relative difference (%) P value
Oral cavity mean 36 60.4 58.5 –0.67 –3.2 –34.21 73.91 .39
Superior constrictor mean 11 87 86.7 –0.11 –0.31 –57.89 24.78 .94
Middle constrictor mean 22 94.9 93.3 –0.56 –1.7 –37.87 37.04 .6
Inferior constrictor mean 21 60.5 60.5 0 –0.03 –17.58 19.84 .99
Parotid ipsilateral mean 28 74.9 65.5 –3.29 –12.53 –43.53 40.54 .013
Parotid contralateral mean 36 46.8 48.9 0.74 4.57 –25 75.38 .08
SMG contralateral mean 25 79.3 74.7 –1.61 –5.83 –60.27 29.11 .16
Larynx mean 26 86.3 77.5 –3.08 –10.17 –28.32 18.57 <.01
Esophagus mean 35 59 57.6 –0.49 –2.3 –17.39 54.24 .38
Spinal cord Dmax 38 111.3 101.7 –3.36 –8.63 –28.68 24.62 <.01
Mandible Dmax 36 202.6 200.8 –0.63 –0.88 –6.88 15.66 .09
Brain stem Dmax 19 101.8 94.5 –2.56 –7.24 –26.15 17.78 .035

Abbreviations: Dmax = maximum dose; OAR = organ at risk; SMG = submandibular gland.

Theoretical benefit if the difference between the scheduled and adapted plan is multiplied over a definitive course of 35 fractions. Hypothetical analysis performed for easier understanding of the dose-per-fraction difference between the 2 plans.

Values in boldface are statistically significant.